Navigation Links
Ambit Biosciences Announces Second Quarter 2014 Operating Results
Date:8/12/2014

SAN DIEGO, Aug. 12, 2014 /PRNewswire/ -- Ambit Biosciences (NASDAQ: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced operating results for the second quarter 2014.  The company will host a conference call today to discuss financial results for the quarter and to provide an operational update for the first half of 2014.

"We are pleased to have initiated our QUANTUM-R Phase 3 trial, our most notable achievement of the first half," said Michael Martino, Ambit's President and Chief Executive Officer.  "The trial is progressing and sites continue to be activated on plan.  This will remain our primary operating focus throughout the year.  We are also pleased with the progress in multiple investigator- and company-sponsored studies that continue to suggest that quizartinib may be a workhorse in the broader fight against AML in newly diagnosed patients and as a maintenance therapy in patients after transplant.  With QUANTUM-R underway, we are taking the next steps to execute this broader vision for quizartinib."

The Company announced the initiation of the Phase 3 QUANTUM-R registrational clinical trial in April of 2014.  This trial compares quizartinib as monotherapy to chemotherapy regimens for relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.  Site initiation and patient enrollment are ongoing, with a planned total enrollment of 326 patients in the United States, Western Europe, Canada and Australia.

At June 30, 2014, the Company had cash and equivalents of $52.8 million, compared to $71.2 million at December 31, 2013.  The decrease of $18.4 million in the first half of 2014 was primarily due to the use of cash to fund operations.

The
'/>"/>

SOURCE Ambit Biosciences
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ambit Biosciences To Announce Second Quarter 2014 Financial Results
2. Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH)
3. Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference
4. Ambit Biosciences Provides Regulatory Update Following FDA Meeting Regarding Quizartinib (AC220)
5. Ambit Biosciences to Announce Third Quarter 2013 Financial and Operating Results and Conference Call
6. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
7. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
8. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
9. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
10. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
11. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... previously announced underwritten public offering of 7,666,667 shares ... price of $11.25 per share. The shares of ... issued upon the exercise in full by the ...
(Date:7/31/2015)... HYDERABAD, India , July 31, 2015 /PRNewswire/ ... Billing and CRM solutions for video, data and cloud ... (PoC) with a leading pharma giant for Internet ... managing different IoT applications offered on subscription model. ... Pharma giant is striving for business ...
(Date:7/30/2015)... (NYSE: RMD ) today announced results for its ... was $453.1 million, a 9 percent increase compared with ... increase on a constant currency basis).  Net income was ... 2014.  Diluted earnings per share for the quarter were ... The results for the quarter ended ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... Naviscan, Inc., announces the European launch of ... two prestigious radiology conferences in Vienna.  On March ... (EUSOBI) Annual Scientific Meeting, a podium presentation will ... data demonstrating PEM,s ability to reduce unnecessary biopsies ...
... March 2, 2011 Pharmacyclics, Inc. (Nasdaq: ... a Btk inhibitor with exceptionally potent anti-arthritis activity in ... the current set of preclinical toxicology studies.  The company ... within approximately 6 months. PCI-45292 has ...
Cached Medicine Technology:Naviscan Announces European Launch of Positron Emission Mammography 2Update on Preclinical Finding and Development Timeline for PCI-45292 2Update on Preclinical Finding and Development Timeline for PCI-45292 3
(Date:8/1/2015)... , ... August 01, 2015 , ... Lume Wellness creators ... is free to download on the Apple AppStore. , The app is designed ... mood, thus acting as a tool to view personal health and use this information ...
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, ... Bowl. In the two weeks that separate the conference championships and the Super Bowl, there ... game will mark the 50th time it has been held and the festivities will take ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... its new store run by GoodThreads. The store can be accessed by visiting ... designs, many of which are customizable. The best part: whenever a product is ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... workshop at its new True North Conference Center. The medical community, social workers, ... Jacksonville community may be more aligned in the effort to better understand and ...
Breaking Medicine News(10 mins):Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3
... at the St. John-Clark Pain Treatment Center in Clearwater, ... Tracy Alan Jones, Brunella Lucchi and strength and conditioning ... dream team. From chicago, Wade joins a staff ... across the country who specialize in integrative neurosomatic therapy, ...
... analysis finds that state policies meant to limit minors, ... the January 15, 2009 issue of CANCER , ... study indicates that additional efforts are needed to reduce ... use increases an individual,s risk of developing skin cancer, ...
... Influenza Immunization Week runs Dec. 8 - 14 , ... record amounts of flu vaccine available, the Pennsylvania Department of Health ... to hockey fans attending the Hershey Bears-Norfolk game at the Giant ... Pennsylvanians comes down with the flu every year, resulting in 8,400 ...
... study found that it is generally safe to withdraw ... seizure-freedom while on the medication. Researchers found that these ... intractable epilepsy. The study will be presented on Sunday, ... in Seattle. , , Epilepsy is a disorder characterized by ...
... BELLEVUE, Wash., Dec. 7 Talyst, a leader ... and,software system designed to help central pharmacies provide ... of remote dispensing,technologies. The products were developed in ... more cost-effective ways to service the,long-term care and ...
... Four studies highlighting late-breaking research advances in the treatment ... today at the 50th Annual Meeting of the American ... Results from a study examining the ability of an ... the inner lining of blood vessels, in patients with ...
Cached Medicine News:Health News:The St. John-Clark Pain Treatment Center Forms Manual Therapy 'Dream Team' 2Health News:State policies have little effect on reducing minors' indoor tanning use 2Health News:PA Department of Health Kicks Off National Influenza Immunization Week With Free Flu Shots at Hershey Bears Game 2Health News:Mayo Clinic finds it generally safe to withdraw anti-seizure medication in children with epilepsy 2Health News:Talyst Moves Patient Safety and Inventory Control Beyond the Hospital 2Health News:Talyst Moves Patient Safety and Inventory Control Beyond the Hospital 3Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 2Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 3Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 4Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 5Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 6Health News:Late-breaking data to be presented at the American Society of Hematology Annual Meeting 7
14mm from Mid-Screw to Tip, Slightly Curved, Sharp Tips; overall length 110mm; Stainless Steel....
9mm Curved Blades with Sharp Pointed Tips; overall length 90mm; Stainless Steel....
4 Gently Curved, Prongs, 5mm Extended, Stainless Steel Tip; with Titanium Handle....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Medicine Products: